Quantcast
Home > Quotes > AMAG
AMAG

AMAG Pharmaceuticals, Inc. Common Stock (AMAG) Quote & Summary Data

$18.29
*  
0.27
1.5%
Get AMAG Alerts
*Delayed - data as of Nov. 21, 2018 11:22 ET  -  Find a broker to begin trading AMAG now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    AMAG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 18.28 / $ 18.31
1 Year Target
19.5
Today's High / Low
$ 18.52 / $ 18.03
Share Volume
72,793
50 Day Avg. Daily Volume
827,168
Previous Close
$ 18.02
52 Week High / Low
$ 26.10 / $ 11.95
Market Cap
631,657,203
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -1.18
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.52

Intraday Chart

Shares Traded

Share Volume:
72,793
50 Day Avg. Daily Volume:
827,168

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -1.18

Trading Range

The current last sale of $18.29 is 53.05% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 18.52 $ 26.10
 Low: $ 18.03 $ 11.95

ETFs with AMAG as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.04% Cambria Global Value ETF (GVAL) -1.68 (-7.08%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

AMAG Pharmaceuticals, Inc., a Delaware corporation, was founded in 1981. We are a biopharmaceutical company focused on developing and delivering important therapeutics, conducting clinical research in areas of unmet need and creating education and support programs for the patients and families we serve. Our currently marketed products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care, including Makena® (hydroxyprogesterone caproate injection), Intrarosa® (prasterone) vaginal inserts, Feraheme® (ferumoxytol injection) for intravenous ("IV") use, and MuGard® Mucoadhesive Oral Wound Rinse. In addition, in February 2017, we acquired the rights to research, develop and commercialize bremelanotide in North America.  ... More ...  


Risk Grade

Where does AMAG fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 18.19
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x